apposters.com
Inkef Capital
Edit

Inkef Capital

https://www.inkefcapital.com
Last activity: 24.12.2025
Active
INKEF Capital is an early stage venture capital firm based in Amsterdam. From the very early stages of a technology or lifescience venture, INKEF Capital supports entrepreneurs building their ideas into successful international businesses.

INKEF Capital covers multiple investment stages but focuses mainly on series A investments. For exceptional teams it also considers seed capital to turn a great idea into a company or growth capital to give a running start-up the next push. INKEF Capital is the partner for the long haul.

Focus areas: Technology and Healthcare
Portfolio
1
Mentions
38
Location: Netherlands, North Holland, Amsterdam
Employees: 11-50
Phone:1389902
Founded date: 2010
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A

Portfolio 1

DateNameWebsiteTotal RaisedLocation
18.12.2025TargED Bio...targedbiopharmaceuticals.com$69.42MNetherland...

Mentions in press and media 38

DateTitleDescription
24.12.2025TargED: €21.5 Million Series A Extension Raised To Advance Targeted Thrombolytic TGD001TargED Biopharmaceuticals B.V., a clinical-stage biotech company developing targeted treatments for thrombotic diseases, has closed a €21.5 million Series A extension led by BioGeneration Ventures (BGV). Existing investors, including Andera...
18.12.2025Dutch-based TargED raises €21.5 million Series A extension to advance targeted treatments for thrombotic diseasesDutch clinical-stage BioTech company TargED Biopharmaceuticals has announced the closing of a €21.5 million Series A extension financing to accelerate the clinical development of its targeted thrombolytic, TGD001. The round was led by BioGe...
29.05.2025Salvia BioElectronics: A New Dawn for Migraine SufferersIn the world of chronic pain, migraines reign supreme. They are not just headaches; they are life-altering storms that can sweep away productivity, joy, and social connections. For millions, the search for relief is a relentless journey. En...
27.05.2025Migraines? This Dutch startup just raised €53 million to transform migraine treatment with its ultra-thin implantEindhoven-based Salvia BioElectronics, a clinical-stage medical device company innovating neuromodulation therapy for patients with chronic migraine, today announced the successful completion of their €53 million Series B financing round. T...
17.03.2022Precirix raises EUR 80m in Series B to advance its pipeline of precision radiopharmaceuticalsBrussels, Belgium, 16 March 2022 – Precirix NV, a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, today announces the closing of a EUR 80m Series B financing round led by new investors INKEF Capit...
15.03.2022Providing “Amazon-level” reach and instant access to over 200 marketplaces, ChannelEngine raises $50 million in Atomico-led roundDutch online marketplace integration platform ChannelEngine has raised $50 million in a Series B funding round. The company's service taps into the growing e-commerce trend of brands selling directly to consumers via marketplaces including ...
20.09.2021Clinical progression and €8M funding for Calypso BiotechCalypso Biotech’s lead program, CALY-002, is a best-in-class therapeutic antibody that binds to and neutralizes interleukin-15 (IL-15). IL-15 controls immune pathways critically involved in disease onset and maintenance, as well as tissue d...
26.08.2021Cardior Raises €64 M Series B to Advance Clinical Pipeline of RNA Therapeutics to Treat Cardiac DiseaseOversubscribed round enables late-stage clinical development of lead candidate, a micro-RNA-132 inhibitor, in heart failure and further accelerates pipeline expansion Hanover, Germany, August 25, 2021 – Cardior Pharmaceuticals, a clinica...
02.06.2021Amsterdam’s financial transaction monitoring system Sentinels trousers £4.9 million in seed roundAmsterdam-based financial transaction monitoring system Sentinels has raised £4.9 million in a seed round led by INKEF Capital. The round also saw participation from a number of Angel Investors including Thijn Lamers and Maikel Lobbezoo, me...
23.04.2021Fresh capital for ONWARD to tackle spinal code injuriesONWARD’s ARC therapy can be delivered by an implantable system called ARC-IM and an external system called ARC-EX. Both platforms are designed to deliver targeted, programmed stimulation of the spinal cord to restore movement, independence,...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In